Full-Time
Global Clinical Lead
Targeted Alpha Therapeutics
Confirmed live in the last 24 hours
Develops targeted radiation therapies for cancer
Senior, Expert
Remote in USA
Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases using targeted radiation. Their products work by delivering precise radiation to affected areas, which helps in making better treatment decisions and providing personalized therapy. Unlike many other biopharmaceutical companies, Telix focuses specifically on areas such as urologic oncology, neuro-oncology, musculoskeletal oncology, and bone marrow conditioning, addressing significant unmet medical needs. The company's goal is to enhance patient care while maintaining ethical practices and environmental responsibility, ensuring that they create sustainable value for patients, shareholders, and employees.
Company Stage
Grant
Total Funding
$63.5M
Headquarters
Melbourne, Australia
Founded
2015